Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Alland

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Journal of Clinical Microbiology|May 6, 2020
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 TestMichael J Loeffelholz, David Alland, Susan M Butler-Wu, et al.
Mbio|December 20, 2018
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasAPradeep Kumar, Glenn C Capodagli, Divya Awasthi, et al.
The Lancet. Infectious Diseases|December 5, 2017
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E Dorman, Samuel G Schumacher, David Alland, et al.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
Nature Medicine|September 6, 2016
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureStephanus T Malherbe, Shubhada Shenai, Katharina Ronacher, et al.
Gates Open Research|March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y Chen, Laura E Via, Lori E Dodd, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Microbe|May 14, 2026
Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB/RIF Ultra testing: a prospective diagnostic accuracy studyMargaretha de Vos, Hien Le, Danaida Marcelo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
High resolution imaging and five-year tuberculosis contact outcomesHanif Esmail, Anna K Coussens, Friedrich Thienemann, et al.
The Lancet. Respiratory Medicine|March 26, 2026
PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort studyHanif Esmail, Friedrich Thienemann, Bianca Sossen, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Journal of Clinical Microbiology|May 6, 2020
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 TestMichael J Loeffelholz, David Alland, Susan M Butler-Wu, et al.
Mbio|December 20, 2018
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasAPradeep Kumar, Glenn C Capodagli, Divya Awasthi, et al.
The Lancet. Infectious Diseases|December 5, 2017
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E Dorman, Samuel G Schumacher, David Alland, et al.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
Nature Medicine|September 6, 2016
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureStephanus T Malherbe, Shubhada Shenai, Katharina Ronacher, et al.
Gates Open Research|March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y Chen, Laura E Via, Lori E Dodd, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Microbe|May 14, 2026
Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB/RIF Ultra testing: a prospective diagnostic accuracy studyMargaretha de Vos, Hien Le, Danaida Marcelo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
High resolution imaging and five-year tuberculosis contact outcomesHanif Esmail, Anna K Coussens, Friedrich Thienemann, et al.
The Lancet. Respiratory Medicine|March 26, 2026
PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort studyHanif Esmail, Friedrich Thienemann, Bianca Sossen, et al.
Pageof 16